1. Home
  2. JXG vs CPIX Comparison

JXG vs CPIX Comparison

Compare JXG & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

N/A

Current Price

$9.00

Market Cap

84.3M

Sector

N/A

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$8.67

Market Cap

92.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JXG
CPIX
Founded
N/A
1999
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.3M
92.3M
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
JXG
CPIX
Price
$9.00
$8.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4K
94.6K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.77
N/A
Revenue Growth
N/A
16.75
52 Week Low
$0.23
$1.85
52 Week High
$12.00
$9.28

Technical Indicators

Market Signals
Indicator
JXG
CPIX
Relative Strength Index (RSI) 55.68 65.14
Support Level $7.37 $5.55
Resistance Level $10.09 N/A
Average True Range (ATR) 0.56 0.50
MACD 0.20 0.08
Stochastic Oscillator 100.00 72.17

Price Performance

Historical Comparison
JXG
CPIX

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products. The Company's operations are located in the PRC and all of the Company's revenue is derived from sales to customers in the PRC region.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: